About iCAD, Inc. 
iCAD, Inc.
Pharmaceuticals & Biotechnology
iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.
Company Coordinates 
Company Details
98 Spit Brook Rd Ste 100 , NASHUA NH : 03062-5737
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 8 Schemes (10.96%)
Foreign Institutions
Held by 15 Foreign Institutions (2.25%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Michael Klein
Executive Chairman of the Board, Chief Executive Officer
Mr. Nathaniel Dalton
Independent Director
Dr. Rakesh Patel
Independent Director
Mr. Andrew Sassine
Independent Director
Dr. Susan Wood
Independent Director
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 103 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.64
-16.98%
3.34






